Outcomes of upfront autologous hematopoietic cell transplantation in patients with multiple myeloma who are 75 years old or older
Abstract
Consolidative autologous hematopoietic stem cell transplantation (AHCT) is commonly used for patients with multiple myeloma (MM). We studied AHCT use and outcomes in patients with MM ≥75 years old.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Aug 10, 2021
- Source ID
- 10.1002/cncr.33831
Entities
People
- Andrew St. Martin
- Anita D'Souza
- David H. Vesole
- Muzaffar Qazilbash
- Nina Shah
- Omar Dávila
- Parameswaran N. Hari
- Pashna N Munshi
- Shaji K Kumar
Organizations
- Georgetown University Medical Center
- Health Resources and Services Administration
- Mayo Clinic
- Medical College of Wisconsin
- Office of Naval Research
- The University of Texas MD Anderson Cancer Center
- University of California, San Francisco